Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Research News
 
Abnormal Mitochondrial Dynamics—Early Event in AD, PD?
5 February 2010. Mitochondria take the stage in three recent papers...
 
Think You Know γ-secretase and p25? Think Again
5 February 2010. There are times in the course of scientific enterprise when researchers must re-evaluate their hypotheses in the face of new, unexpected data...
 
Going Wild About the Latest TDP-43 Mouse Models
4 February 2010. The new animal models for TDP-43 proteinopathies, a series of related neurodegenerative diseases, are coming out at a fast and furious rate...
 
Shape-shifting Prions: Infectious Recombinant and Myelin-Minding Normal
3 February 2010. The cellular prion protein has received a lot of attention recently for its potential role in amyloid-β (Aβ) toxicity...
 
GO TO ALL RESEARCH NEWS  
 
 
In the spotlight

AlzSWAN in the News
From the department of kvelling: Our very own AlzSWAN knowledge base is featured in a Nature news story about computations tools to help scientists navigate the scientific literature. Nature interviewed Alzforum members about how they are using AlzSWAN. The article includes nice images of our graphical mapping tool. Kudos to the AlzSWAN team! Image credit: Nature Publishing Group
Copper Mountain Moguls—Struggling to Get Over Aβ
Copper Mountain, Colorado
View larger image
Like skiers on the mogul run, it seems everywhere Alzheimer disease researchers turn, there’s that bump to get over—Aβ. The harder the field tries to avoid the peptide, as in last week’s Keystone Symposium “Alzheimer’s Disease Beyond Aβ” held at the ski town of Copper Mountain, Colorado, the more imposing it appears. Organized by Tony Wyss-Coray and JoAnne McLaurin, the symposium was conceived to consider alternative therapeutic approaches to targeting Aβ, a strategy that
has so far failed to deliver. But as one researcher aptly framed it, “beyond” could mean both apart from, or downstream of, Aβ. Both interpretations were evident during the symposium, where most presenters couldn’t help mentioning Aβ. Check this space for Tom Fagan’s stories on the news, Aβ-esque or otherwise. Image credit: Tom Fagan
Can CREB Save Memory?
Knight Vision—SIRT1 Aids ADAM10, Slays Aβ
Rat-a-tat—New Model Comes a Knockin’
Death and Trophin Receptors—New Insight, New Drugs?
 
 
What's New

Desperately Seeking Research Participants - Posted 8 February 2010
Non-invasive, Non-drug Dementia Clinical Trial by Quietmind Foundation, a nonprofit research and training organization.
 
Comments - Posted 5 February 2010
Read remarks by Mark A. Smith, Hyoung-gon Lee, Rudy Castellani, George Perry, Xiongwei Zhu about Roe CM et al.
PAPER: Cancer linked to Alzheimer disease but not vascular dementia.
 
Comments - Posted 5 February 2010
Read remarks by Xiongwei Zhu about Zhao XL et al.
PAPER: Expression of beta-amyloid Induced age-dependent presynaptic and axonal changes in Drosophila.
 
Comments - Posted 5 February 2010
Read remarks by Bingwei Lu about Geisler S et al.
PAPER: PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
 
Comments - Posted 5 February 2010
Read remarks by Bingwei Lu about Zhao XL et al.
PAPER: Expression of beta-amyloid Induced age-dependent presynaptic and axonal changes in Drosophila.
 
Comments - Posted 5 February 2010
Read remarks by Lucia Chavez-Gutierrez about Zhao G et al.
PAPER: {gamma}-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch and Amyloid Precursor Protein in the Absence of Nicastrin.
 
Jobs - Posted 5 February 2010
Director, Geriatric Research, Education and Clinical Center (GRECC): VA Puget Sound Health Care System & Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington.
 
Patient Care - Posted 5 February 2010
We've added the Alzheimer's Association Virtual Library to our Patient Care page.

SEE MORE  
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
Alzheimer's Research & Therapy

Announcing Alzheimer's Research & Therapy, a new online peer-reviewed journal which publishes open access research articles of outstanding quality in Alzheimer's research.
Alzheimer's Research & Therapy
AlzRisk: An AD Epidemiology Database
The AlzRisk Epidemiology Database provides a publicly available collection of published studies on the impact of putative environmental risk factors and protective factors related to Alzheimer disease in longitudinal cohort studies.
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Forum Calendar

Check out our recent Webinar/Live Discussion: Betwixt and Intermixed—Dementia With Lewy Bodies, held 15 June 2009.

Topics in Neurodegeneration
Download Powerpoint Presentations created by top experts in neurodegenerative disease research. Available for educational or personal use. Edited by Daniel M. Michaelson, PhD, and Tobias Hartmann, PhD.

ISOA

The Drug Development Company Database and Tutorial represent the collaborative efforts of the Alzheimer's Drug Discovery Foundation (ADDF)/Institute for the Study on Aging (ISOA) and the Alzheimer Research Forum. Our thanks to ADDF, Jens Eckstein, and the Advisory Board for bringing this project to fruition.
ISOA
Polls
       
To reduce your AD risk, you
 
engage in strenuous physical activity
 
consume oxidant-rich foods
 
take resveratrol
 
overwork your brain
 
rest your brain
 
buy Elan stock
 
many of the above
 
none of the above
 
 
 
 
 
Archived Polls
 
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad